Provides telemedicine and remote healthcare services, focusing on digital health solutions and medical consultations.
SHL Telemedicine Ltd., along with its subsidiaries, specializes in the development and global marketing of personalized telemedicine solutions across Israel, Europe, and beyond. At the forefront of its offerings are innovative devices like smartheart, a mobile 12-lead ECG device designed for early detection of heart attacks. The company also features CardioSen'C, a cellular-digital 12-lead ECG transmitter, and Cardio'B, a portable device facilitating the transmission of comprehensive ECG data.
In addition to its range of advanced medical devices, SHL Telemedicine provides a central communication module that facilitates the seamless transmission of medical data from various monitoring devices to its telemedicine centers. These devices include those for monitoring blood pressure, weight, oxygen saturation (TelePulse Oximeter), breath exhalation (TeleBreather), and sugar levels, such as the TelePress remote blood pressure monitor.
Catering to a diverse clientele including physicians, hospitals, health insurance funds, and individual patients, SHL Telemedicine operates at the intersection of electronic and telecommunication technologies. The company collaborates extensively with renowned institutions like the Mayo Clinic, Hebrew University of Jerusalem, and Hadassah Medical Center to advance research and enhance patient care outcomes. Founded in 1986 and headquartered in Tel Aviv, Israel, SHL Telemedicine continues to lead the telemedicine industry with its commitment to innovation and improving healthcare accessibility globally.